Celgene Corp (CELG)

CELG (NASDAQ:Drugs) EQUITY
$116.09
neg -0.11
-0.10%
Today's Range: 114.92 - 116.54 | CELG Avg Daily Volume: 5,358,300
Last Update: 05/22/15 - 3:59 PM EDT
Volume: 2,650,031
YTD Performance: 3.88%
Open: $115.50
Previous Close: $116.20
52 Week Range: $74.00 - $129.06
Oustanding Shares: 793,144,382
Market Cap: 92,686,852,481
6-Month Chart
TheStreet Ratings Grade for CELG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 13 14 15
Moderate Buy 1 1 1 1
Hold 3 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.44 1.50 1.47 1.45
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 40.02
Price Earnings Comparisons:
CELG Sector Avg. S&P 500
40.02 39.90 27.02
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-5.86% 56.88% 234.77%
GROWTH 12 Mo 3 Yr CAGR
Revenue 18.10 0.58 0.16
Net Income 37.90 0.52 0.15
EPS 42.00 0.72 0.20
Earnings for CELG:
EBITDA 2.94B
Revenue 7.67B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $1.02 $1.11 $4.11 $5.54
Number of Analysts 3 3 2 2
High Estimate $1.10 $1.23 $4.13 $5.54
Low Estimate $0.98 $1.04 $4.09 $5.53
Prior Year $0.80 $0.88 $3.36 $4.11
Growth Rate (Year over Year) 27.92% 26.52% 22.32% 34.67%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Many of these stocks are off to the races.
Some companies are so strong that they buck the rotation.
Remember that rotations are vicious.
And it's not the favorable macroeconomic climate.
The quarter investors couldn't resist is now making every stock pay.
Merger rumors abound around salesforce.com.
Consumer, health care names lead market lower.

Columnist Conversations

There is $1.25 billion to sell market on close as of 347PM.
Goldman Sachs say Yellen is "balanced." Their view is that the Fed Chair downplayed weak 1Q2015 growth and sai...
There was nothing new at all out of Yellen's speech today. She expects rates to rise this year but repeats aga...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.